| BID | 1.08 | ASK | 1.09 | ||
| Open | 1.10 | Previous Close | 1.14 | ||
| Pre-Market | 1.16 | After-Market | - | ||
| 0.02 1.75% | - - |
| Target Price | 4.00 | Analyst Rating | Strong Buy 1.00 | |
| Potential % | 268.66 | Finscreener Ranking | ★★★★+ 57.77 | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★★★ 51.26 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★★★+ 53.18 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 5.16 | Earnings Rating | Strong Buy | |
| Market Cap | 14.82M | Earnings Date | 10th Aug 2023 | |
| Alpha | 0.01 | Standard Deviation | 0.54 | |
| Beta | 0.59 |
Today's Price Range 1.081.20 | 52W Range 0.97003.20 | 5 Year PE Ratio Range -2.20-1.90 |
Summary:
Sell
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | -9.88% | ||
| 1 Month | -10.94% | ||
| 3 Months | -12.31% | ||
| 6 Months | 2.70% | ||
| 1 Year | 1.79% | ||
| 3 Years | -84.59% | ||
| 5 Years | -98.16% | ||
| 10 Years | -99.51% |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -158.22 | |||
ROE last 12 Months | -75.05 | |||
ROA (5Y Avg) | -41.85 | |||
ROA last 12 Months | -48.60 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -109.24 | |||
Return on invested Capital Q | -6.74 | |||
Return on invested Capital Y | -69.80 | |||
Assets Turnover | 0.80 | |||
Receivables Turnover | 5.40 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -1.70 | ||||
| 1.65 | ||||
| 1.48 | ||||
| - | ||||
| -3.80 | ||||
| -1.00 | ||||
| 1.65 | ||||
| 1.00 | ||||
| 17.90M | ||||
| Forward PE | -1.77 | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 4.40 | ||||
| 4.80 | ||||
| 0.03 | ||||
| 0.15 | ||||
| -2 770.20 | ||||
| Leverage Ratio | 1.80 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 27.80 | ||||
| -74.20 | ||||
| -67.10 | ||||
| -312.60 | ||||
| -28.81 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 14.00M | ||||
| 1.08 | ||||
| 76.10 | ||||
| 14.26 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q03 2023 | -0.24 | -0.24 | 0.00 |
| Q02 2023 | -0.17 | -0.20 | -17.65 |
| Q01 2023 | -0.33 | -0.14 | 57.58 |
| Q03 2022 | -0.36 | -0.33 | 8.33 |
| Q02 2022 | -0.30 | -0.28 | 6.67 |
| Q01 2022 | -0.19 | -0.63 | -231.58 |
| Q04 2021 | -0.32 | -0.49 | -53.12 |
| Q03 2021 | -0.24 | -0.46 | -91.67 |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 9/2023 QR | -0.27 | 6.90 | Positive |
| 9/2023 FY | -0.86 | 1.15 | Positive |
| 12/2023 QR | -0.28 | 0.00 | - |
| 9/2024 FY | -0.68 | 2.86 | Positive |
| Next Report Date | - |
| Estimated EPS Next Report | -0.24 |
| Estimates Count | 1 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 50.45K |
| Shares Outstanding | 13.66K |
| Shares Float | 11.50M |
| Trades Count | 249 |
| Dollar Volume | 55.47K |
| Avg. Volume | 81.60K |
| Avg. Weekly Volume | 39.79K |
| Avg. Monthly Volume | 29.15K |
| Avg. Quarterly Volume | 175.85K |
Applied DNA Sciences Inc. (NASDAQ: APDN) stock closed at 1.14 per share at the end of the most recent trading day (a -5.79% change compared to the prior day closing price) with a volume of 59.58K shares and market capitalization of 14.82M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 61 people. Applied DNA Sciences Inc. CEO is James A. Hayward.
The one-year performance of Applied DNA Sciences Inc. stock is 1.79%, while year-to-date (YTD) performance is -31.33%. APDN stock has a five-year performance of -98.16%. Its 52-week range is between 0.97 and 3.2, which gives APDN stock a 52-week price range ratio of 5.16%
Applied DNA Sciences Inc. currently has a PE ratio of -1.70, a price-to-book (PB) ratio of 1.65, a price-to-sale (PS) ratio of 1.48, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -48.60%, a ROC of -109.24% and a ROE of -75.05%. The company’s profit margin is -28.81%, its EBITDA margin is -67.10%, and its revenue ttm is $14.00 Million , which makes it $1.08 revenue per share.
Of the last four earnings reports from Applied DNA Sciences Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.24 for the next earnings report. Applied DNA Sciences Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Applied DNA Sciences Inc. is Strong Buy (1), with a target price of $4, which is +268.66% compared to the current price. The earnings rating for Applied DNA Sciences Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Applied DNA Sciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Applied DNA Sciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 18.77, ATR14 : 0.10, CCI20 : -217.98, Chaikin Money Flow : -0.38, MACD : -0.05, Money Flow Index : 37.14, ROC : -7.32, RSI : 37.30, STOCH (14,3) : 12.50, STOCH RSI : 0.00, UO : 24.45, Williams %R : -87.50), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Applied DNA Sciences Inc. in the last 12-months were:
Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a provider of DNA-based supply chain, anti-counterfeiting, and anti-theft technology. The company provides its products and services under the brand of SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. It serves clients in various industries including government/military, security and asset marking, industrial parts, pharmaceuticals, textiles and apparel, and printing and packaging. The company has operational footprints across the United States, Europe, Asia, and others.
CEO: James A. Hayward
Telephone: +1 631 840-8800
Address: 50 Health Sciences Drive, Stony Brook 11790, NY, US
Number of employees: 61
TipRanks News for APDN
Tue, 15 Aug 2023 12:01 GMT Analysts Conflicted on These Technology Names: Applied DNA Sciences (APDN), Enthusiast Gaming Holdings (EGLX) and Splunk (SPLK)
- TipRanks. All rights reserved.Fri, 14 Jul 2023 10:30 GMT Analysts Offer Insights on Technology Companies: Applied DNA Sciences (APDN) and Mogo Finance Technology (MOGO)
- TipRanks. All rights reserved.
